Clinical trials
Recruiting Phase 2 trials in Chile
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 19 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 11 |
| AstraZeneca | 6 |
| Sanofi | 3 |
| Bristol-Myers Squibb | 2 |
| Pontificia Universidad Catolica de Chile | 2 |
| Contineum Therapeutics | 1 |
| Immunovant Sciences GmbH | 1 |
| Incyte Corporation | 1 |
| MapLight Therapeutics | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Graves Disease | 2 |
| Idiopathic Pulmonary Fibrosis | 2 |
| Lung Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Acute Coronary Syndrome | 1 |
| Adenoma, Islet Cell | 1 |
| Alzheimer Disease | 1 |
| Arthritis, Psoriatic | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.